Polsinelli Podcasts - FDA Denies Amgen Citizen Petition in Biosimilar Dispute
As we previously reported, on January 11, 2024, Regeneron Pharmaceuticals, Inc. (“Regeneron”) moved to establish a multi-district litigation (“MDL”) for its aflibercept BPCIA litigation, and to transfer its case against...more